-
Posted by
Two Blokes Jul 11 -
Filed in
Stock
-
10 views
Shares of Glenmark Pharmaceuticals jumped 10% in early trade on Friday, a day after a unit of the Indian drugmaker signed an exclusive licensing deal with U.S. peer AbbVie for its cancer treatment.
